021-51111890
购物车（）
sales@molnova.cn
ELA-14 (human)
CAS No. 1886973-05-2
ELA-14 (human) ( —— )
产品货号. M30770 CAS No. 1886973-05-2
Potent apelin (APJ) receptor agonist (Ki = 0.93 nM). Bioactive fragment of ELA-32. Activates Gαi1 pathway and β-arrestin-2 recruitment. Reduces arterial pressure in rat hearts. Active in vivo.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥3078 | 有现货 |
|
| 10MG | ￥4665 | 有现货 |
|
| 25MG | ￥7961 | 有现货 |
|
| 50MG | ￥12183 | 有现货 |
|
| 100MG | ￥18270 | 有现货 |
|
| 200MG | ￥28512 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称ELA-14 (human)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Potent apelin (APJ) receptor agonist (Ki = 0.93 nM). Bioactive fragment of ELA-32. Activates Gαi1 pathway and β-arrestin-2 recruitment. Reduces arterial pressure in rat hearts. Active in vivo.
-
产品描述Potent apelin (APJ) receptor agonist (Ki = 0.93 nM). Bioactive fragment of ELA-32. Activates Gαi1 pathway and β-arrestin-2 recruitment. Reduces arterial pressure in rat hearts.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number1886973-05-2
-
分子量1707.03
-
分子式C75H119N25O17S2
-
纯度>98% (HPLC)
-
溶解度water:1 mg/mL
-
SMILESCSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Murza et al (2016) Discovery and structure-activity relationship of a bioactive fragment of ELABELA that modulates vascular and cardiac functions. J.Med.Chem. 59 2962 PMID:
产品手册
关联产品
-
5-bromo-2-(2,6-dioxo...
5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione 是一种化合物。
-
6-Acryloyloxyhexyl p...
6-Acryloyloxyhexyl phosphater (PA21) is a novel phosphate-binding agent, which is an iron-based reagent, and can be used for the treatment of hyperphosphatemia in chronic kidney disease.
-
Inotuzumab
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) 是人源化的 IgG4，κ 抗体靶向人 CD22。Inotuzumab 与毒素奥加米星 (ozogamicin) 相连接可作为抗体-活性分子偶联物 (ADC)。Inotuzumab 可于急性淋巴细胞白血病和非霍奇金淋巴瘤的研究。
